These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22125022)

  • 1. [Atypical subtrochanteric fractures after long-term bisphosphonate therapy].
    Czerwiński E
    Endokrynol Pol; 2011; 62 Suppl 2():42-5. PubMed ID: 22125022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical subtrochanteric fractures after long-term bisphosphonate therapy.
    Czerwiński E
    Endokrynol Pol; 2011; 62(1):84-7. PubMed ID: 21365585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
    Rizzoli R; Akesson K; Bouxsein M; Kanis JA; Napoli N; Papapoulos S; Reginster JY; Cooper C
    Osteoporos Int; 2011 Feb; 22(2):373-90. PubMed ID: 21085935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
    Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
    J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subtrochanteric pathological fracture on bisphosphonates].
    Mathonet PY; Willems S; Ciornohac JF
    Rev Med Liege; 2018 Feb; 73(2):56-60. PubMed ID: 29517866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical fractures as a potential complication of long-term bisphosphonate therapy.
    Sellmeyer DE
    JAMA; 2010 Oct; 304(13):1480-4. PubMed ID: 20924014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical subtrochanteric fractures associated with long-term use of bisphosphonates.
    López-López L; Vilá LM
    P R Health Sci J; 2011 Dec; 30(4):211. PubMed ID: 22263304
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
    Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
    J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.
    Warren C; Gilchrist N; Coates M; Frampton C; Helmore J; McKie J; Hooper G
    ANZ J Surg; 2012 Dec; 82(12):908-12. PubMed ID: 22943522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
    Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving data about subtrochanteric fractures and bisphosphonates.
    Shane E
    N Engl J Med; 2010 May; 362(19):1825-7. PubMed ID: 20335574
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S
    Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
    Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do we know about atypical femoral fractures? Insights and enigmas.
    Audran M; Cortet B; Thomas T;
    Joint Bone Spine; 2011 Dec; 78(6):568-71. PubMed ID: 21592839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: a cause for concern?
    Yoon RS; Hwang JS; Beebe KS
    J Bone Joint Surg Br; 2011 Oct; 93(10):1289-95. PubMed ID: 21969423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical subtrochanteric fractures in Korean hip fracture study.
    Lee YK; Kim TY; Ha YC; Song SH; Kim JW; Shon HC; Chang JS; Koo KH
    Osteoporos Int; 2017 Oct; 28(10):2853-2858. PubMed ID: 28612307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related subtrochanteric femoral fractures.
    Gunawardena I; Baxter M; Rasekh Y
    Am J Geriatr Pharmacother; 2011 Jun; 9(3):194-8. PubMed ID: 21470918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.